Geode Capital Management, LLC Design Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 758,550 shares of DSGN stock, worth $4.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

758,550

Previous 707,971 7.14%

Holding current value

$4.74 Million

Previous $2.37 Million 72.08%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.19 - $5.88 $161,347 - $297,404	50,579 Added 7.14%	758,550 $4.08 Million
Q2 2024 Aug 09, 2024	BUY	$3.23 - $4.77 $77,755 - $114,828	24,073 Added 3.52%	707,971 $2.37 Million
Q1 2024 May 13, 2024	BUY	$2.27 - $4.03 $48,019 - $85,250	21,154 Added 3.19%	683,898 $2.76 Million
Q4 2023 Feb 13, 2024	BUY	$1.99 - $2.76 $55,767 - $77,346	28,024 Added 4.42%	662,744 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$2.05 - $8.14 $4,356 - $17,297	-2,125 Reduced 0.33%	634,720 $1.5 Million
Q2 2023 Aug 11, 2023	BUY	$4.99 - $7.64 $19,146 - $29,314	3,837 Added 0.61%	636,845 $4.01 Million
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $164,972 - $293,051	29,995 Added 4.97%	633,008 $3.65 Million
Q4 2022 Feb 13, 2023	BUY	$7.86 - $17.2 $206,749 - $452,428	26,304 Added 4.56%	603,013 $6.19 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $1.99 Million - $3.62 Million	141,584 Added 32.54%	576,709 $9.64 Million
Q2 2022 Aug 12, 2022	BUY	$9.91 - $17.33 $677,645 - $1.19 Million	68,380 Added 18.65%	435,125 $6.09 Million
Q1 2022 May 13, 2022	BUY	$11.17 - $20.89 $170,945 - $319,700	15,304 Added 4.35%	366,745 $5.92 Million
Q4 2021 Feb 11, 2022	BUY	$13.64 - $21.41 $1.27 Million - $2 Million	93,409 Added 36.2%	351,441 $7.52 Million
Q3 2021 Nov 12, 2021	BUY	$13.99 - $20.03 $73,755 - $105,598	5,272 Added 2.09%	258,032 $3.79 Million
Q2 2021 Aug 13, 2021	BUY	$19.02 - $29.78 $4.09 Million - $6.4 Million	215,060 Added 570.45%	252,760 $5.03 Million
Q1 2021 May 12, 2021	BUY	$29.52 - $41.49 $1.11 Million - $1.56 Million	37,700 New	37,700 $1.13 Million

Others Institutions Holding DSGN

# of Institutions

102

Shares Held

31M

Call Options Held

2.3K

Put Options Held

16.5K

View Full List

About Design Therapeutics, Inc.

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $349M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

More about DSGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Design Therapeutics, Inc. Transaction History